Citadel Advisors’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
KL
OCMI
NIM
GKFF
Citadel Advisors's ASPN Position: Q2 2026 in Review
Citadel Advisors reduced its Aspen Aerogels (ASPN) stake by 59% in Q2 2026, selling an estimated $1.68M and leaving 238,731 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #7192.
Citadel Advisors first reported a position in ASPN in Q4 2015 and has held it in 26 quarters since. The position peaked at $15M in Q2 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.
- Citadel Advisors held 238,731 shares of Aspen Aerogels worth $1.51M as of Q2 2026.
- Citadel Advisors sold 342,456 Aspen Aerogels shares in Q2 2026, an estimated $1.68M.
- Aspen Aerogels made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7192 holding.
- Citadel Advisors first reported a position in Aspen Aerogels in Q4 2015 and has held it in 26 quarters since.
- Citadel Advisors's Aspen Aerogels position peaked at $15M in Q2 2024.
- 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.